Spruce Biosciences Stock Price on April 9, 2024
| SPRB Stock | USD 0.55 0.02 3.77% |
If you're considering investing in Spruce Stock, it is important to understand the factors that can impact its price. As of today, the current price of Spruce Biosciences stands at 0.55, as last reported on the 28th of November, with the highest price reaching 0.57 and the lowest price hitting 0.52 during the day. Spruce Biosciences appears to be risky, given 3 months investment horizon. Spruce Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Spruce Biosciences, which you can use to evaluate the volatility of the company. Please review Spruce Biosciences' Risk Adjusted Performance of 0.0477, coefficient of variation of 1906.75, and Semi Deviation of 2.36 to confirm if our risk estimates are consistent with your expectations.
At present, Spruce Biosciences' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 62.6 M, whereas Total Stockholder Equity is forecasted to decline to about 65.5 M. . At present, Spruce Biosciences' Price Book Value Ratio is projected to slightly grow based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.07, whereas Price To Sales Ratio is forecasted to decline to 8.94. Spruce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Spruce |
Sharpe Ratio = 0.102
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SPRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.3 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Spruce Biosciences is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spruce Biosciences by adding it to a well-diversified portfolio.
Price Book 0.4238 | Enterprise Value Ebitda (0.23) | Price Sales 3.0816 | Shares Float 24.9 M | Wall Street Target Price 2.3333 |
Related Headline
Day One Headline on 9th of April 2024
Disposition of 20000 shares by Blackman Samuel C. of Day One... by Blackman Samuel C.
Filed transaction by Day One Biopharmaceuticals Officer Head Of Rd. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Spruce Biosciences Valuation on April 9, 2024
It is possible to determine the worth of Spruce Biosciences on a given historical date. On April 9, 2024 Spruce was worth 0.79 at the beginning of the trading date compared to the closed value of 0.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Spruce Biosciences stock. Still, in general, we apply an absolute valuation method to find Spruce Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spruce Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Spruce Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 0.83 | 0.83 | 0.79 | 0.79 | 635,256 | |
04/09/2024 | 0.79 | 0.79 | 0.75 | 0.77 | 618,738 |
| 0.78 | 0.78 | 0.74 | 0.75 | 732,149 |
| Backtest Spruce Biosciences | | | Spruce Biosciences History | | | Spruce Biosciences Valuation | Previous | Next |
Spruce Biosciences Trading Date Momentum on April 9, 2024
| On April 10 2024 Spruce Biosciences was traded for 0.75 at the closing time. The top price for the day was 0.78 and the lowest listed price was 0.74 . The trading volume for the day was 732.1 K. The trading history from April 10, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.60% . The trading price change against the current closing price is 9.09% . |
Spruce Biosciences Fundamentals Correlations and Trends
By evaluating Spruce Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Spruce Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Spruce financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Spruce Biosciences Stock history
Spruce Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spruce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spruce Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spruce Biosciences stock prices may prove useful in developing a viable investing in Spruce Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.5 M | 24.9 M | |
| Net Loss | -41.6 M | -43.6 M |
Spruce Biosciences Quarterly Net Working Capital |
|
Spruce Biosciences Stock Technical Analysis
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Spruce Biosciences Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Spruce Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Spruce Biosciences November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Spruce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spruce Biosciences shares will generate the highest return on investment. By undertsting and applying Spruce Biosciences stock market strength indicators, traders can identify Spruce Biosciences entry and exit signals to maximize returns
Spruce Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Spruce Biosciences' price direction in advance. Along with the technical and fundamental analysis of Spruce Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spruce to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0477 | |||
| Jensen Alpha | 0.0519 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0131 | |||
| Treynor Ratio | 0.1783 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |